Skip to main content
SpringerLink
Log in

Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi

  • Published:
Indian Journal of Clinical Biochemistry Aims and scope Submit manuscript

Abstract

Xanthelasma Palpebrarum is the most common of the xanthomas with asymptomatic, symmetrical, bilateral, soft, yellow, velvety, polygonal papules around the eyelids. Xanthelasmas may be associated with hyperlipidemia. This prospective study included 66 clinically diagnosed patients with Xanthelasma Palpebrarum and 50 controls with non-inflammatory skin disorders. Serum triglyceride, cholesterol, HDL, LDL and VLDL estimated in all cases indicated that patients with Xanthelasma Palpebrarum have underlying lipid abnormalities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bergam R. The pathogenesis and clinical significance of Xanthelasma Palpebrarum. J Am Acad Dermatol 1994 Feb; 30(2 Pt 1): 236–42.

    Google Scholar 

  2. Reddy SN B, Singh G, Pandey SS, Tiwari D. Clinical and lipid profile studies in Xanthelasma Palpebrarum. I J D V L 1983; 49(3): 127–31

    Google Scholar 

  3. Chhetri MK, Chowdhary ND, De B. Xanthelasma Palpebrarum. J Asso Phy Ind 1967; 15(9): 405–12.

    CAS  Google Scholar 

  4. Gangopadhyay BN, Dey SK, Mitra C, Pal D. Chaudhuri Serum lipid profile in Xanthelasma Palpebrarum. Ind J Dermatol 1998; 43(2): 53–7.

    Google Scholar 

  5. Vacca JB, William AK, Broun GO. Clinical observations regarding xanthelasma. Ann Int Med 1959; 51: 1019–31.

    PubMed  CAS  Google Scholar 

  6. Segal P, Insull W Jr, Chambless LE, Stinnett S, LaRosa JC, Weissfeld L, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Circulation 1987; 73(1 Pt 2): 1108–18.

    Google Scholar 

  7. Wolff Eugene, Xanthelasma Palpebrarum. Tumor of sebaceous glands. Br J Dermatol 1951; 63: 296–302.

    Article  Google Scholar 

  8. Thompson JA. Xanthelasma associated with throtoxicosis. J Clin Endocr 1965; 25: 758–60.

    Google Scholar 

  9. Scott J, Winterbourn CC. Low-density lipoprotein accumulation in actively growing xanthomas. J Atheroscl Res 1967; 7: 207–23.

    Article  CAS  Google Scholar 

  10. Bergman R, Kasif Y, Aviram M, Maor I, Ullman Y, Gdal OM, et al. Normolipidemic xanthelasma palpebrarum: lipid composition, cholesterol metabolism in monocyte derived macrophages and plasma lipid peroxidation. Acta Derm Venereol 1996; 76(2): 107–10.

    PubMed  CAS  Google Scholar 

  11. Marcelo GH, Janis PM. Xanthelasma. 2005 May 12. Available from: URL: eMedicine Specialties

  12. Watanabe A, Yoshimura A, Wakasugi T, Tatami R, Ueda K, Ueda R, et al. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Atherosclerosis 1981; 38(3–4): 283–90.

    Article  PubMed  CAS  Google Scholar 

  13. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of serum cholesterol. Clin Chem 1974; 20: 470.

    PubMed  CAS  Google Scholar 

  14. Buccolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476–82.

    Google Scholar 

  15. Jonson A, Sigfusson N. Letter: Significance of xanthelasma palpebrarum in normal population. Lancet 1976; 1: 372.

    Article  Google Scholar 

  16. Ribera M, Pinto X, Argimon JM, Fiol C, Pujol R, Ferrandiz C. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 1995; 99(5): 485–90.

    Article  PubMed  CAS  Google Scholar 

  17. Pedace FJ, Winkelmann RK. Xanthelasma Palpebrarum. J A M A 1965; 13: 893–4.

    Google Scholar 

  18. Dean FD. Xanthelasma and hyperproteinemia. Clinica Chimica Acta 1976; 66(2): 189–93.

    Article  CAS  Google Scholar 

  19. Tracey A Schmucker, Hampton Roy. Xanthelasma. 2006 May 17. Available from: URL: eMedicine Specialties

  20. Farmer JA, Gotto AM Jr. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol 2003; 92(1A): 3i-9i.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biochemistry, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital, 110001, New Delhi, India

    A. Jain, P. Goyal & P. K. Nigam

  2. Department of Dermatology & STD, Lady Hardinge Medical College and Smt. Sucheta Kriplani Hospital, New Delhi, India

    H. Gurbaksh & R. C. Sharma

Authors
  1. A. Jain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. Goyal
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. P. K. Nigam
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H. Gurbaksh
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. C. Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Jain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jain, A., Goyal, P., Nigam, P.K. et al. Xanthelasma Palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi. Indian J Clin Biochem 22, 151–153 (2007). https://doi.org/10.1007/BF02913335

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02913335

Key words

Search

Navigation